Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

107.75
-1.8500-1.69%
Volume:885.51K
Turnover:96.15M
Market Cap:6.26B
PE:-32.83
High:110.13
Open:108.51
Low:107.31
Close:109.60
52wk High:130.23
52wk Low:73.16
Shares:58.08M
Float Shares:55.40M
Volume Ratio:1.02
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2819
EPS(LYR):-3.2819
ROE:-26.38%
ROA:-5.80%
PB:9.54
PE(LYR):-32.83

Loading ...

Stock Track | Glaukos Soars 23.88% on Strong Q3 Results and Analyst Upgrades

Stock Track
·
Oct 30, 2025

Glaukos price target raised to $120 from $110 at JPMorgan

TIPRANKS
·
Oct 30, 2025

Top Premarket Gainers

MT Newswires Live
·
Oct 30, 2025

Glaukos Is Maintained at Buy by BTIG

Dow Jones
·
Oct 30, 2025

U.S. RESEARCH ROUNDUP- Alphabet, Boeing, KLA

Reuters
·
Oct 30, 2025

Glaukos Corp : Jefferies Cuts Target Price to $130 From $160

THOMSON REUTERS
·
Oct 30, 2025

Glaukos Corp. Reports Record Q3 Sales Growth

TIPRANKS
·
Oct 30, 2025

Stock Track | Glaukos Soars 18% on Strong Q3 Results, Raised Guidance, and Positive 2026 Outlook

Stock Track
·
Oct 30, 2025

Stock Track | Glaukos Shares Soar 18% on Strong Q3 Results and Raised Guidance

Stock Track
·
Oct 30, 2025

Medical device maker Glaukos posts smaller-than-expected loss in Q3 on strong demand in U.S.

Reuters
·
Oct 30, 2025

Glaukos Reports Record Q3 2025 Sales Growth

TIPRANKS
·
Oct 30, 2025

Stock Track | Glaukos Soars 14% After Hours on Strong Q3 Results and Upbeat Future Guidance

Stock Track
·
Oct 30, 2025

Glaukos Q3 Sales USD 133.5 Million Vs. IBES Estimate USD 122.5 Million

Reuters
·
Oct 30, 2025

Glaukos Corporation Reports Third Quarter Net Loss of $16.2 Million

Reuters
·
Oct 30, 2025

Glaukos Projects 2026 Net Sales of $600 Million to $620 Million

Reuters
·
Oct 30, 2025

Glaukos Corp: Preliminary 2026 Net Sales Guidance of $600 Mln to $620 Mln.

THOMSON REUTERS
·
Oct 30, 2025

Glaukos Corp. Advances in Glaucoma Treatment with New Clinical Trial

TIPRANKS
·
Oct 28, 2025

Stifel Nicolaus Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
Oct 27, 2025

Wells Fargo Upgrades Glaukos Corp to Overweight From Equalweight, Adjusts Price Target to $120 From $92

MT Newswires Live
·
Oct 27, 2025

Glaukos Raised to Overweight From Equal-Weight by Wells Fargo

Dow Jones
·
Oct 27, 2025